Prophylactic Treatment of Skin Rash Associated With EGFR Inhibitor Therapy

Clinical trial NCT04239846 · COMPLETED

Trial details

NCT number: NCT04239846
Sponsor: TWi Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

EGFR Inhibitor-Induced Skin Rash

Start date: 2019-10-02
Primary completion: 2021-05-12
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.